[PRLD] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
01-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -0.58%
YoY- -3.72%
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
Revenue 3,000 0 0 0 0 0 -
PBT -32,271 -30,608 -29,958 -30,687 -16,760 -6,734 36.75%
Tax 0 -279 -448 -356 0 0 -
NP -32,271 -30,608 -29,510 -30,687 -16,760 -6,734 36.75%
Tax Rate - - - - - - -
Total Cost 35,271 30,608 29,510 30,687 16,760 6,734 39.21%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
NP Margin -1,075.70 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
EPS -0.43 -0.45 -0.62 -0.66 -0.44 -0.21 15.39%
EPS Diluted -0.43 -0.45 -0.62 -0.66 -0.44 -0.21 15.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.